Today in News History
On July 12, several notable moments in the history of News stand out. In 1849, William Osler, Canadian physician and author (died 1919) was born. In 1862, The Medal of Honor is authorized by the United States Congress. In 1863, Albert Calmette, French physician, bacteriologist, and immunologist (died 1933) was born. In 1910, Charles Rolls, English engineer and businessman, co-founded Rolls-Royce Limited (born 1877) passed away. In 1933, Victor Poor, American engineer, developed the Datapoint 2200 (died 2012) was born. In 1935, Satoshi Ōmura, Japanese biochemist and academic, Nobel Prize laureate was born. In 2000, Charles Merritt, Canadian colonel and politician, Victoria Cross recipient (born 1908) passed away. In 2006, The 2006 Lebanon War begins. In 2013, Amar Bose, American businessman, founded the Bose Corporation (born 1929) passed away. In 2014, Valeriya Novodvorskaya, Russian journalist and politician (born 1950) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.
Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Heartflow scales AI diagnostics while Iovance drives personalized cancer therapies, each faces unique financial and operational risks in 2026.
Narrative Intelligence Brief
This article was published by The Motley Fool, a source frequently categorized with a lean left bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of The Motley Fool, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.
More from The Motley Fool
July 12, 2026
Don't Be Misled: Common Myths About Index Funds Debunked
July 12, 2026
SpaceX Stock Just Dropped Below Its Debut Price. Is the Stock a Buy?
July 12, 2026
Meta Platforms Just Unveiled a Shocking New Artificial Intelligence (AI) Strategy
July 12, 2026
Subprime Auto Loans Just Hit Their Worst Delinquency Rate in 32 Years. Here's What It Means for Lenders.
July 12, 2026
Why Oklo Stock Sank 27% In The First Half of 2026
Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.More Coverage
Discussion
"jude bellingham"
Tuchel angry at 'lucky' and 'sloppy' England – can 'mentality' be enough?
Tuchel angry at 'lucky' and 'sloppy' England – can 'mentality' be enough?
2026 World Cup Golden Boot Odds: Jude Bellingham Skyrockets After Brace
How other outlets are covering this story
Compare narratives across 2 related reports from 2 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.
Coverage bias distribution
2 sources
Left 50%
Center 0%
Right 50%
The Motley Fool
· Jul 7, 2026
This Stock Stumbled Last Year. Now It's the First Half's Best Performing Mega-Cap Healthcare Stock. Is It Too Late to Buy?
This company's recovery efforts are bearing fruit.
Seeking Alpha
· Jul 7, 2026
Bioventus: I See A Better Business Trading At A Fair Price (Upgrade)
Bioventus: I See A Better Business Trading At A Fair Price (Upgrade)
Topics:
Related coverage for "Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?": The Motley Fool — This Stock Stumbled Last Year. Now It's the First Half's Best Performing Mega-Cap Healthcare Stock. Is It Too Late to Buy?. Seeking Alpha — Bioventus: I See A Better Business Trading At A Fair Price (Upgrade)